IncFact
Company Profiles: Revenue, Growth, Competition

SUPERNUS PHARMACEUTICALS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Supernus Pharmaceuticals

Access the complete profile.

Supernus Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes32541
325412 Pharmaceutical Preparation Manufacturing
Address1550 East Gude Drive
Rockville, MD 20850

www.supernus.com


Supernus Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Scientific Research & Development Services industry.


Supernus Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Supernus Pharmaceuticals is a publicly traded company on NGM using the ticker symbol SUPN. Detailed information on company financials and operating reports can be found here: NGM: SUPN



Supernus Pharmaceuticals Annual Revenue and Growth Rate

Supernus Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Supernus Pharmaceuticals's revenues are gauged from an analysis of company filings.



Investor Activity

Supernus Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
February 16, 2012 3 100%$30 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Supernus Pharmaceuticals is developing and marketing. Supernus Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
YESFYNA
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
07/30/2020
QEBSEROS
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
06/16/2020
EBSEROS
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
04/22/2020

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Supernus Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Supernus Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Supernus Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Supernus Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to Supernus Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
HENRY M. JACKSON FOUNDATION FOR ADVANCEMENT OF MILITARY MEDICINEBethesda, MD100 
OTSUKA AMERICA PHARMACEUTICALRockville, MD95 
SUPERNUS PHARMACEUTICALSRockville, MD67 
PANUM TELECOMPotomac, MD41 
CYSTIC FIBROSIS FOUNDATIONBethesda, MD40 
HUMAN GENOME SCIENCESRockville, MD37 




Future Competition: Supernus Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Supernus Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Supernus Pharmaceuticals Competitors